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SUMMARY 
Amylin is a peptide hormone that is synthesized by pancreatic ß-cells and secreted in 
response to nutrient stimuli. It acts as a satiation signal, inhibiting food intake by limiting 
meal size. The adipocyte-derived hormone leptin exerts trophic effects on projections from its 
central site of action. In the current study, we investigated the neurotrophic effects of amylin 
and leptin on the development of projections from the area postrema (AP), amylin’s central 
site of action, to the nucleus of the solitary tract (NTS) in mouse pups and possible functional 
consequences.  
 We implanted crystals of the lipophilic tracer DiI into the AP of male amylin-deficient 
IAPP-/- mice and their wildtype IAPP+/+ littermates on postnatal day 10 (P10), 14 (P14) and 60 
(P60), and of leptin-deficient ob/ob and wildtype (wt) littermates on P14, to label projections 
to the NTS.  
In IAPP+/+ mice, AP-NTS projection fiber density regressed from P10 to P14, indicating 
neuronal remodeling processes. There was no difference in fiber density or signal transduction 
between the two genotypes on P60. However, there were indications of compensatory 
receptor upregulation mechanisms in P60 IAPP-/- mice. 
In ob/ob mice, AP-NTS fiber density was significantly reduced on P14 compared to wt 
littermates. Our findings extend the concept that amylin and leptin function as developmental 
factors in the maturation of brain circuits maintaining energy balance. 
 V 
ZUSAMMENFASSUNG 
Amylin ist ein Peptidhormon, welches nach Nahrungsaufnahme sezerniert wird und als 
Sättigungssignal wirkt. Das Hormon Leptin wird von weissen Fettzellen sezerniert und übt 
trophische Effekte auf neuronale Projektionen seiner zentralen Zielstruktur aus. Wir 
untersuchten die neurotrophe Wirkung von Amylin und Leptin auf die Entwicklung 
neuronaler Projektionen von der Area Postrema (AP), der zentralen Zielstruktur von Amylin, 
zum Nucleus tractus solitarii (NTS) bei Mäusewelpen, sowie mögliche funktionelle Folgen. 
Wir implantierten Kristalle des lipophilen Fluoreszenzfarbstoffes DiI in die AP von 
Amylin-defizienten IAPP-/- Mäusen und Wildtyp IAPP+/+ Wurfgeschwistern am postnatalen 
Tag 10 (P10), 14 und 60, und von Leptin-defizienten ob/ob und Wildtyp (wt) 
Wurfgeschwistern an P14, um Projektionen zum NTS zu quantifizieren 
Die Dichte der AP-NTS Projektionsfasern von IAPP+/+ Mäusen reduzierte sich zwischen 
P10 und P14, was auf neuronale Umgestaltung hinweist. An P60 konnte kein Unterschied in 
der Faserdichte oder der Signalübermittlung zwischen den Genotypen gefunden werden; es 
gab jedoch Hinweise auf eine kompensatorisch vermehrte Rezeptorexpression in P60 IAPP-/- 
Mäusen. 
Die Faserdichte von ob/ob Mäusen an P14 war im Vergleich zu wt Wurfgeschwistern 
signifikant reduziert. Unsere Resultate erweitern das Konzept, dass Amylin und Leptin als 
Entwicklungsfaktoren bei der Reifung von neuronalen Schaltkreisen dienen, welche in die 
Aufrechterhaltung der Energiehomöostase involviert sind. 
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1 Introduction 
1.1 Energy homeostasis 
Maintenance of energy homeostasis, i.e. the balance between energy intake and energy 
expenditure, is crucial to keep body weight stable (Berridge 2004). The modern world is 
confronted with a wide increase in the prevalence of obesity (Popkin and Doak 1998) and of 
related disorders such as diabetes mellitus, atherosclerosis and hypertension; together, they 
express the dramatic consequences of imbalances in energy homeostasis (Molavi et al. 2006).  
The hormonal system controlling energy intake consists of two main categories, satiation 
signals and adiposity signals, which are sensed and integrated by the central nervous system 
(CNS) (Luquet and Magnan 2009; Woods et al. 2004).  
 
1.1.1 Satiation signals 
It is widely accepted today that the main control of short term food intake and meal size 
in particular is not exerted at the time of meal onset but at meal termination; therefore, the 
amount of food consumed is controlled, thus allowing individuals flexibility and adaptation to 
their environment (Woods et al. 2000). This control depends on the exact measurement of 
amount and composition of the food already eaten, which is provided by hormonal and 
neuronal enteroceptive signals. Sham feeding studies have shown that those signals mainly 
arise from the distal stomach or small intestine, as animals with open gastric fistula consume 
significantly larger meals (Davis and Campbell 1973). 
The first identified satiation signal was cholecystokinin (CCK). CCK dose-dependently 
reduces meal size in rats if administered prior to a meal (Gibbs et al. 1973). CCK is a peptide 
secreted by the duodenal and jejunal mucosa in response to luminal nutrients. It facilitates 
digestion by stimulating enzyme secretion of exocrine pancreas and liver, and by gallbladder 
contraction (Moriyasu et al. 1994). In addition, CCK’s satiating effect is mediated by a 
stimulation of CCK receptors on sensory fibers of the vagus nerve that project to the nucleus 
of the solitary tract in the hindbrain (Moran et al. 1997), and possibly by receptors located in 
the hypothalamus (Blevins et al. 2000). 
Similar to CCK many other gastrointestinal peptides are released in response to food 
intake and have been reported to inhibit feeding, such as peptide YY(3-36)  (Batterham et al. 
2002), gastrin releasing peptide (Stein and Woods 1982), glucagon-like peptide-1 (Naslund et 
al. 1999), neuromedin B (Ladenheim et al. 1996), apolipoprotein A-1V (Fujimoto et al. 1993), 
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somatostatin (Lotter et al. 1981) and enterostatin (Okada et al. 1991; Shargill et al. 1991). 
Furthermore, amylin (Lutz et al. 1994) and glucagon (Geary 1990), which are secreted from 
the pancreatic islets in response to food intake, also reduce meal size when administered 
peripherally before the meal. Except for CCK and probably amylin and glucagon, the 
physiological relevance of the eating inhibitory effects of these hormones still needs to be 
confirmed. 
Most of those signals stimulate the hindbrain either directly at sites lacking a functional 
blood brain barrier, such as amylin in the area postrema (AP) (Lutz et al. 1995a), or by 
activating afferent vagal fibers projecting to the hindbrain, which are also activated by 
gastrointestinal mechano- and chemosensors (Anand and Pillai 1967).  
 
1.1.2 Adiposity signals 
Adiposity signals are hormones secreted in direct proportion to the amount of body fat. 
The best characterized are leptin, secreted directly from white adipocytes (Dua et al. 1996; 
Havel 1999; Maffei et al. 1995), and insulin, which is secreted from pancreatic beta cells 
(Bjorntorp 1997; Polonsky et al. 1988). Both can cross the blood-brain barrier by saturable 
transport (Banks et al. 1997; Banks et al. 1996) and are thought to act directly on the arcuate 
nucleus of the hypothalamus (ARH) by stimulating neurons containing pro-opiomelanocortin 
(POMC) and by inhibiting neurons containing agouti-related protein and neuropeptide Y 
(AgRP/NPY). POMC neurons release α-melanocyte stimulating hormone (αMSH), which 
exerts catabolic and anorexigenic actions. AgRP/NPY neurons release AgRP and NPY into 
the paraventricular nucleus of the hypothalamus; further, they release gamma aminobutyric 
acid (GABA) within the ARH, which acts anabolic and orexigenic mainly by inhibiting 
POMC neurons (Baskin et al. 1999; Benoit et al. 2002). In addition, insulin and leptin have 
both been shown to modulate the sensitivity to satiation signals. Hence, excessive weight 
gain, leading to increased plasma leptin and insulin levels, results in an increased sensitivity to 
the meal size reducing effects of CCK (Matson et al. 1997; Riedy et al. 1995). 
Any disruption in leptin signaling results in severe weight gain, which is apparent in 
leptin deficient (ob/ob) and leptin receptor deficient (db/db) mice. (Friedman and Halaas 
1998; Tartaglia 1997). 
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1.2 Amylin 
1.2.1 Structure, tissue expression and secretion 
Amylin is a 37–amino-acid peptide that was first isolated from amyloid-containing 
pancreata of humans with type 2 diabetes (Clark et al. 1987; Cooper et al. 1987). Because of 
its origin, the isolated peptide was first named “diabetes-associated peptide” or “islet amyloid 
polypeptide” (IAPP), but was renamed to amylin after the discovery that it was also present 
under non-pathologic conditions (Cooper et al. 1988), acting as a hormone. Today, amylin is 
the most commonly used term, but the term IAPP, designated 1987 by Westermark 
(Westermark et al. 1987), is often used synonymously. Characterization of the amylin gene 
and the amino acid sequence revealed close homology between amylin and calcitonin-gene 
related peptide (CGRP), an alternate splicing product of the calcitonin gene (Mosselman et al. 
1988; Westermark et al. 1986). Amylin and CGRP form, along with adrenomedullin (AM), 
calcitonin (CT) and intermedin, the CT super family (Wimalawansa 1997). 
After the first isolation of amylin from the pancreas, and the detection of amylin-like 
immunoreactivity in pancreatic islets (Johnson et al. 1988), it was later found to be 
colocalized with insulin in pancreatic beta-cells (Denijn et al. 1992). The observation that 
amylin secretion was modulated by factors also known to modulate insulin secretion, such as 
glucose, carbachol (Jamal et al. 1993), the amino acid arginine (Ogawa et al. 1990) or 
somatostatin (Mitsukawa et al. 1990) led to the assumption that amylin was co-secreted from 
pancreatic beta-cells with insulin. Since then, immunoreactivity has also been found in some 
other tissues such as the gut, especially in the pyloric antrum (Asai et al. 1990), the nervous 
system (Mulder et al. 1995; Skofitsch et al. 1995), osteoblasts (Gilbey et al. 1991) and in rat 
and human placenta (Caminos et al. 2009). However, expression levels in these tissues are 
much lower than in the pancreas. 
The amylin receptor consists of a calcitonin receptor that is associated with one of three 
receptor activity modifying proteins (RAMPs). This association leads to an alteration in 
receptor pharmacology from CT-preferring to amylin-preferring (Muff et al. 1999; Zumpe et 
al. 2000). 
 
1.2.2 Influence on nutrient fluxes 
Amylin plays a very important role in the control of gastrointestinal nutrient transit and 
absorption. Being secreted in response to nutrient stimuli, its main action is to slow glucose 
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absorption and, consequently, the rise in postprandial plasma glucose (Kolterman et al. 1995). 
This effect is mediated by different actions of amylin, i. e. suppression of glucagon secretion 
(Gedulin et al. 1997) that leads to lower endogenous glucose production (Unger and Orci 
1977), delayed gastric emptying (Gedulin et al. 2006; Kong et al. 1997; Young et al. 1995) 
and inhibition of gastric acid secretion (Guidobono et al. 1994). The effect on gastric 
functions is prevented by hypoglycemia (Gedulin and Young 1998), which is thought to be a 
“fail-safe” reflex to prevent insufficient nutrient availability during hypoglycemia (Young 
1997). 
There is strong evidence that central sites mediate the gastric effects of amylin, namely 
the area postrema (AP) in the hindbrain, which displays a very high binding density for 
amylin. Furthermore, lesion of the area postrema abolishes the gastric effects (Young 1997), 
but importantly also the anorectic effect of amylin (Lutz et al. 1998). 
 
1.2.3 Effects on food intake 
Amylin acts as a classical satiation signal, as it is released during meals and dose-
dependently reduces meal size after intraperitoneal and subcutaneous injection. Hepatic portal 
infusion during spontaneous meals inhibited feeding within minutes and led to a reduction in 
meal size and duration (Lutz et al. 1995b). In addition, direct amylin infusion into the AP 
reduced food intake significantly in fasted rats. Further, strong evidence for a physiological 
relevance of the satiating effect of amylin was provided by the application of the amylin 
antagonist AC 187. AC 187 increased food intake, mainly by increasing meal size, after 
peripheral injection or after central infusion into the AP (Mollet et al. 2004; Reidelberger et 
al. 2004). The anorectic effect of amylin is not based on a conditioned taste aversion or 
unspecific effects such as a reduction in drinking; it therefore seems to be specific (Morley et 
al. 1997). 
 
1.2.4 Amylin and diabetes mellitus 
Type 1 diabetes mellitus is presumably caused by an autoimmune destruction of 
pancreatic β cells and is therefore characterized by an absolute deficiency in insulin secretion. 
As amylin is co-secreted with insulin, patients suffering from type 1 diabetes also show a 
deficiency in amylin secretion. Therefore, amylin agonists in combination with insulin are 
used for the treatment of type 1 diabetes, mainly due to the inhibitory effects of glucagon 
INTRODUCTION 
 5 
secretion and gastric emptying (Edelman and Caballero 2006; Heptulla et al. 2005; Schmitz et 
al. 2004). 
Type 2 diabetes mellitus (T2DM) is a multifactorial disease influenced by genetic, 
environmental and endogenous factors (Hayden and Tyagi 2001). It is characterized by 
insulin resistance and, in a progressive stage, β-cell failure (Ferrannini 1998). In patients with 
T2DM, islet amyloid is a typical finding present in the pancreatic islets of the vast majority 
(Oosterwijk et al. 1995), and is thought to play an important role in the pathogenesis of beta-
cell failure. 
 
1.3 Area postrema 
The area postrema is located on the dorsal surface of the medulla oblongata at the caudal 
end of the fourth ventricle. It belongs to the sensory circumventricular organs (CVO), which 
are characterized by fenestrated capillaries, high permeability, extensive vascularization and 
their location around the third and fourth ventricle (Gross 1992; Krisch et al. 1978). Together 
with the organum vasculosum of the lamina terminalis (OVLT) and the subfornical organ 
(SFO), the AP belongs to the so-called sensory CVOs (Johnson and Gross 1993).  
Other brain regions are protected from circulating molecules, such as hormones and 
glucose, but also toxins, and from changes in osmolarity and electrolytes by a functional 
blood-brain barrier (BBB), which is essential for the maintenance of neuronal signaling 
(Abbott 2004; Abbott et al. 2006). Due to the lack of the BBB in sensory CVOs, they are 
ideally situated to act as an interface between the periphery and the brain and represent target 
sites for circulating humoral signals. This is supported by the high density of binding sites for 
different peptide hormones (Barberis and Tribollet 1996; Gebke et al. 2000; Krisch 1992; 
Mangurian et al. 1999; Mendelsohn et al. 1987; Nakajima et al. 1986; Sexton et al. 1994; 
Weindl et al. 1992) in all sensory CVOs and by the ability of most of these peptides to evoke 
electrophysiological responses in neurons of sensory CVOs (Carpenter et al. 1983; Ferguson 
1991; Gutman et al. 1988; Riediger et al. 1999; Schmid et al. 1998; Yang and Ferguson 
2002). To exert their important regulatory effects on various physiological functions, CVOs 
are connected to other brain regions by numerous projections, mostly to essential autonomic 
centers in the hypothalamus and the medulla oblongata (Armstrong et al. 1996; Ferguson et al. 
1984; Lind 1988; Lind et al. 1982; Miselis 1982; Miselis et al. 1979; Weiss and Hatton 1990). 
The AP has major efferent projections to the nucleus of the solitary tract (NTS) (Shapiro 
and Miselis 1985), which receives inputs from visceral (Kalia and Sullivan 1982; Rinaman et 
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al. 1989) and cardiovascular (Palkovits and Zaborszky 1977; van Giersbergen et al. 1992) 
afferents. It also projects to the parabrachial nucleus (PBN) (Lanca and van der Kooy 1985), 
which receives gustatory and viscerosensory inputs (Hermann and Rogers 1985). Both the 
NTS and the PBN are strongly connected to other brain regions, amongst others the 
paraventricular nucleus of the hypothalamus (PVN) (McKellar and Loewy 1981) and other 
hypothalamic structures (Sakumoto et al. 1978), the bed nucleus of the stria terminalis 
(Sofroniew 1983) and the central nucleus of the amygdala (Ricardo and Koh 1978). Minor 
neuronal connections from the AP project to the nucleus ambiguus and the dorsal motor 
nucleus of the vagus nerve, which are both involved in the control of heart rate and cardiac 
function (Wang et al. 2001), and to dorsal regions of the tegmental nuclei (Shapiro and 
Miselis 1985). 
The AP also receives afferent inputs from mostly the same regions it projects to. Major 
afferents originate from the NTS and PBN; other inputs come from the PVN and the vagus 
nerve (Papas and Ferguson 1990; Vigier and Rouviere 1979). 
In summary, the AP is a highly interconnected brain area and sends and receives 
projections to a number of other brain regions, which are part of different autonomic circuits. 
It holds a key position in integrating peripheral and central signals and has been shown to be, 
together with the NTS, the major site of abdominal sensory inputs (Hyde and Miselis 1983) 
 
1.3.1 Functions of the AP 
The AP plays a crucial role in the control of various autonomic physiological functions, 
including emesis, taste sensitivity, cardiovascular control and, most important for this study, 
the control of eating. 
 Borison (Borison 1974; Borison and Wang 1953) first discovered the existence of 
chemoreceptors in the AP that respond to certain drugs by a stimulation of vomiting. His 
findings led to the conclusion that the AP is important for the detection of ingested toxins and 
for their elimination from the gastrointestinal tract. This was corroborated by studies using AP 
lesioned animals, which did not show an emetic response to a variety of drugs (Bhandari et al. 
1992; Jovanovic-Micic et al. 1989; Miller and Nonaka 1992).  
Berger et al. (Berger et al. 1973) studied the formation of conditioned taste aversions 
(CTA), which are learned responses leading to the avoidance of food that had previously been 
associated with toxic effects; they showed that the AP plays a critical role in the formation of 
CTA by scopolamine methyl nitrate. Later studies supported this, showing the same effects 
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for lithium chloride (Kosten and Contreras 1989; Ritter et al. 1980) and amphetamine (Rabin 
and Hunt 1989). 
The existence of arginine vasopressin (AVP) (Barberis and Tribollet 1996) and 
angiotensin II (ANGII) (Mendelsohn et al. 1987) receptors suggested a role of the AP in 
cardiovascular control. AVP and ANGII effects on blood pressure and heart rate were 
abolished in AP lesioned rats (Bishop et al. 1987; Fink et al. 1987; Undesser et al. 1985); 
studies on brainstem slices confirmed a role of the AP in mediating ANGII and AVP effects, 
as both ANGII and AVP had inhibitory and excitatory effects on AP neurons (Cai and Bishop 
1995; Lowes et al. 1995). 
The AP expresses a high density of binding sites for different hormones and 
neuropeptides involved in the control of eating, such as amylin (Sexton et al. 1994), peptide 
YY (Trinh et al. 1996), CCK (Carlberg et al. 1992; Hyde and Peroutka 1989), glucagon-like 
peptide-1 (Goke et al. 1995) and others. As indicated earlier, most of the effects of amylin on 
nutrient fluxes and food intake seem to be mediated by the AP (see chapters 1.2.2 and 1.2.3). 
In addition to the abolition of gastric and anorectic effects in AP lesioned rats (Lutz et al. 
2001; Young 1997) and the direct effects of the amylin antagonist AC 187 when infused into 
the AP (Mollet et al. 2004), electrophysiological studies revealed an excitatory effect of 
amylin on AP neurons, which could also be blocked by AC 187 (Riediger et al. 2001).  
Another method used for the detection of neuronal stimulation in vivo is the 
immunohistochemical detection of the immediate early gene product c-Fos. c-Fos is a 
transcription factor, which exerts either stimulatory or inhibitory effects on gene transcription. 
Under baseline conditions, c-Fos expression is very low in most neurons, whereas after 
depolarizing stimuli gene expression is rapidly induced, peaking between 60 and 90 minutes 
and persisting for 2 to 5 hours (Hoffman et al. 1993; Sharp et al. 1991). C-Fos is therefore a 
widely accepted experimental marker for neuronal activation. 
In line with its excitatory effects on AP neurons, amylin also induces a strong c-Fos 
expression in the AP after peripheral amylin injection (Riediger et al. 2001; Riediger et al. 
2004; Rowland et al. 1997). In addition to the AP, amylin also elicits a c-Fos response in the 
NTS-LPBN-CeA axis which transmits the excitatory amylin signal to rostral brain areas 
(Rowland et al. 1997). In AP lesioned rats, c-Fos expression in these areas was attenuated 
after amylin injection (Riediger et al. 2004), which provides further evidence for a role of the 
AP as a primary target site for peripheral amylin. 
Together, all these studies point to a decisive role of the AP in amylin action. 
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1.4 The arcuate nucleus of the hypothalamus 
The hypothalamus plays a key role in the control of physiological functions and 
behavioral patterns that ensure survival, such as the control of eating, drinking, defense and 
reproduction (Luiten et al. 1987). Regarding the control of eating, the hypothalamus serves as 
the major central site for the integration of peripheral satiation signals and adiposity signals 
reflecting energy stores (Elmquist et al. 2005; Minor et al. 2009). The arcuate nucleus of the 
hypothalamus (ARH), together with the paraventricular nucleus of the hypothalamus, is 
particularly important for the control of food intake and energy balance because it functions as 
a receptive site for these signals. 
The ARH is located at the base of the third ventricle and is interconnected with the 
brainstem (Abbott et al. 2005; Ter Horst et al. 1989) and other hypothalamic nuclei, including 
the dorsomedial nucleus (DMH), the lateral hypothalamic area (LHA) and the paraventricular 
nucleus (PVH) (Kalra et al. 1999). 
The two main populations of neurons involved in the control of feeding and energy 
balance have briefly been described before (see chapter 1.1.2). Activation of POMC neurons 
results in the secretion of αMSH, which acts on melanocortin receptors of secondary neuron 
populations in the PVH and other hypothalamic nuclei (Belgardt et al. 2009; Wikberg et al. 
2003). The stimulation of secondary neurons leads to an increase in energy expenditure and a 
decrease in food intake; the exact mechanisms though, especially how this information is 
translated into specific motor patterns of eating, are not completely understood yet. Activation 
of AgRP/NPY neurons on the other hand leads to an increase in food intake by two different 
mechanisms. AgRP directly inhibits the activation of secondary neurons by αMSH, whereas 
NPY has stimulatory effects on hunger, fat storage and weight gain (Beck et al. 1992; Stanley 
et al. 1986; Zarjevski et al. 1993) while decreasing body temperature and energy expenditure 
(Billington et al. 1991; Hwa et al. 1999). POMC knockout mice, as well as POMC-deficient 
humans, overeat and develop extreme obesity (Yaswen et al. 1999), while acute ablation of 
AgRP/NPY neurons led to a decrease in food intake and body weight (Gropp et al. 2005; 
Luquet et al. 2005). 
Both populations of neurons express receptors for leptin and insulin that seem to be 
directly targeted by leptin and insulin (Baskin et al. 1988; Mercer et al. 1996). Both hormones 
stimulate POMC neurons and inhibit AgRP/NPY neurons (Pinto et al. 2004; Ziotopoulou et 
al. 2000).  
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1.5 Amylin knockout mice 
To investigate the physiological functions of endogenous amylin, Gebre-Medhin et al. 
created mice lacking amylin by a targeted deletion of the IAPP gene (Gebre-Medhin et al. 
1998a). IAPP-deficient mice (IAPP-/-) were born from heterozygous (IAPP+/-) parents in 
Mendelian frequencies and appeared healthy; the typical distribution of insulin-
immunoreactivity was indicative of normal morphology of the islet of Langerhans in adult 
IAPP-/- mice. Screening of IAPP-/- mice and wildtype (IAPP+/+) controls from the age of 6 – 
42 weeks showed no difference in basal glucose levels. From 30 weeks of age, IAPP-/- 
animals showed a tendency towards lower insulin levels, but the difference was not significant 
(Gebre-Medhin et al. 1998a). Male IAPP-/- mice showed an increased plasma insulin response 
in intravenous and oral glucose tolerance tests (IVGTT; OGTT), a faster decline in plasma 
glucose concentrations in IVGTT and a lower plasma glucose peak in OGTT. 
In a subsequent study, the role of amylin in nociception and inflammatory response was 
tested in IAPP-/- mice. Nociceptive behavior was significantly reduced compared to controls, 
but this effect was not due to altered inflammatory response (Gebre-Medhin et al. 1998b). The 
reduced response to noxious stimuli in IAPP-/- mice implied a pro-nociceptive action of 
amylin in sensory neurons, as the inflammatory response seemed to be unaltered. 
Alternatively, amylin may exert trophic effects on nerve fibers involved in nociceptive 
transmission, which is interesting in context with the present study.  
A further effect seen in amylin deficient mice was a reduction in bone mass. IAPP-/- 
males and females showed a 50 % decrease in bone mass due to a decrease in cortical and 
trabecular thickness and in connectivity between trabeculae, which is typical of osteoporosis. 
All hormonal and metabolic parameters measured were normal; therefore bone effects were 
not secondary to metabolic changes but probably specific to the deficit in endogenous amylin 
(Dacquin et al. 2004). 
While food consumption did not differ significantly between groups, male IAPP-/- mice 
showed a significant increase in body mass between the age of 18 weeks (Gebre-Medhin et al. 
1998a) and about 4 months compared to wildtypes, but not in mice older than 4 months (Lutz 
2006).  
Recent studies from our group showed a significant reduction in food intake shortly after 
amylin injection in adult IAPP+/+ and in IAPP-/- mice. IAPP-/- mice therefore seem to be 
similarly sensitive to exogenously administered amylin and its inhibitory effects on eating as 
control mice, which is in principle consistent with the findings of Gebre-Medhin and 
colleagues about basal food intake (unpublished data). 
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1.6 Leptin-deficient ob/ob mice 
In 1949, Ingalls et al. discovered some young mice in a breeding stock that showed a 
very plump phenotype. With the occurrence in more litters, it became clear that a hereditary 
mutation was the most likely cause of this phenotype. Affected mice gained weight more 
rapidly than their littermates and became massively obese, which is why the mutation was 
called obese and designated by the symbol ob (Ingalls et al. 1950). In 1994, Zhang et al. 
cloned and sequenced the mouse ob gene and the human homologue; they were also able to 
identify its product, the Ob protein, which today is better known as leptin (Zhang et al. 1994). 
Daily intraperitoneal injections of recombinant leptin led to a reduction in body weight, food 
intake and body fat mass in ob/ob mice (Halaas et al. 1995; Pelleymounter et al. 1995).  
Mice carrying another gene mutation, diabetes (db), which leads to a nearly identical 
phenotype as the ob mutation (Hummel et al. 1966), showed massively elevated circulating 
leptin levels (Halaas et al. 1995). As they did not show a reduction in body weight or food 
intake after leptin administration (Halaas et al. 1995), it was assumed that they might be 
resistant to leptin; this was confirmed by the finding that the db gene encodes for the leptin 
receptor (Chen et al. 1996; Chua et al. 1996).  
 
1.6.1 Neurotrophic effects of leptin 
Ahima and colleagues reported about the existence of a postnatal leptin surge in mouse 
pups during their first week of life (Ahima et al. 1998). This was an unexpected finding 
because the elevated leptin levels were not associated with a reduction in food intake. This 
was interpreted as an insensitivity of the neonatal brain to leptin (Mistry et al. 1999). As 
circulating hormones, such as thyroid hormone (Bernal, 2002; Oppenheimer et al., 1987) and 
sex hormones (Madeira and Lieberman, 1995; McEwen et al., 1986; Simerly, 2002), have 
been known to strongly influence brain development perinatally, especially in the limbic 
system and the hypothalamus (Bernal 2002; Madeira and Lieberman 1995; McEwen et al. 
1986; Oppenheimer et al. 1987; Simerly 2002), it was speculated that leptin might also 
function as an early postnatal developmental signal in neonates (Ahima et al. 1999; Ahima 
and Hileman 2000; Steppan and Swick 1999). This view was supported by the finding that 
brains of ob/ob mice were smaller and weighed less than brains of normal mice. Daily leptin 
administration for two weeks increased brain weight and cell number, indicating a possible 
defect in brain development in ob/ob mice (Steppan and Swick 1999).  
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Bouret et al. used the lipophilic fluorescent tracer DiI (1,1’-dioctadecyl-3,3,3’,3’-
tetramethylindocarbocyanine perchlorate) which labels axonal projections (Honig and Hume 
1989), to investigate the developmental role of leptin in projections from the ARH to other 
hypothalamic nuclei. They showed that projections to the PVH, the DMH and the LHA 
developed from postnatal day 5 (P5) to P16. Most interestingly, this coincided with the time 
of the postnatal leptin surge (Bouret et al. 2004a; b). 
Projections in ob/ob mouse pups of different ages were profoundly underdeveloped 
compared to their wild-type littermates. This disruption seemed to be permanent as a 
difference could still be seen in adult mice. Daily leptin treatment from of neonatal ob/ob 
mouse pups P4 to P12 led to a reversal of the effect, i.e. the density of ARH to PVH was 
similar to wildtype control mice. Further, incubation of brain slices containing the ARH with 
leptin induced the growth of neurites from the ARH, suggesting a direct action of leptin on 
arcuate neurons to stimulate axon growth. However, leptin treatment of adult mice was unable 
to reconstitute a normal neurocircuitry (Bouret et al. 2004b). These findings clearly 
demonstrate that leptin plays an important role in the development and programming of neural 
feeding circuits in the hypothalamus of neonatal mouse pups, and that the time window for 
leptin to exert this effect is limited to the early postnatal phase. 
 
1.7 Aim of the study 
In addition to its effects of ingestive behavior and gastric function, amylin exerts trophic 
effects on the fetal and postnatal kidneys, where it stimulates proliferation of proximal tubule 
cells that are mainly responsible for sodium and water reabsorption (Harris et al. 1997; 
Wookey et al. 1998). It furthermore has effects on bone formation and mineralization by 
stimulating the proliferation of osteoblasts and inhibiting osteoclast activity (Cornish et al. 
1995). Amylin expression is already present in the fetal pancreas (Mulder et al. 1997), which 
suggests a potential developmental role of amylin during ontogeny. 
Based on the findings that leptin exerts trophic effects on the formation of projections 
from the ARH to other hypothalamic nuclei (Bouret et al. 2004b), our group recently 
investigated whether amylin, similar to leptin, has neurotrophic effects on neuronal 
projections in the CNS. As the AP has been identified as amylin’s central site of action (see 
chapter 1.3.1), projections from the AP to the NTS were analyzed first, using and adapting the 
DiI axonal labeling technique described by Bouret et al. (2004a,b) We showed a significant 
reduction of fiber projections from the AP to the NTS in IAPP-/- mice on postnatal day 10 
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(P10) and a tendency towards lower fiber density on P14. We also found a reduced fiber 
density in P14 IAPP+/+ mice compared to P10 IAPP+/+, indicative of neural remodeling 
processes (unpublished data). 
The first aim of the current study was to analyze additional data of male P14 mice, which 
allowed us gender-specific evaluation. Further, we wanted to determine the consequences of 
amylin deficiency on neural circuits from the AP to the NTS in adult mice. Because receptor 
upregulation compensatory to hormone deficiency has been described for different hormones 
including leptin (Huang et al. 1997), we also analyzed the density of calcitonin receptors in 
the AP of adult mice. With the objective of investigating amylin’s effect on ARH-PVH 
projection development in a future study, our second aim was the establishment of DiI 
implantation into the ARH as described by Bouret et al. (2004a,b). 
Furthermore, we hypothesized that leptin may also influence the development of AP 
projections in the hindbrain; for this reason we investigated AP-NTS projections in P14 ob/ob 
mice. 
 
We wanted to answer the following questions: 
 
• Does the neurotrophic function of amylin observed in early postnatal mice have an 
impact on the neuroanatomy of adult IAPP-/- mice? Are there functional 
consequences in signal transduction in the AP/NTS region? 
 
• Does amylin have an influence on calcitonin receptor density in the AP of adult 
mice? 
 
• Does leptin also have neurotrophic effects on the development of projections from 
the AP to the NTS? 
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2 Materials and methods 
2.1 Animals 
2.1.1 Generation of amylin knockout mice 
The generation of amylin ko mice was first described by Gebre-Medhin et al. (Gebre-
Medhin et al. 1998a). To create amylin deficient mice, a 10.5 kbp fragment containing the 
murine IAPP gene was cloned from a genomic mouse Balb/c library (Stratagene) by plaque 
hybridization to the human IAPP cDNA. The replacement of an 890 bp SphI/BamHI fragment 
containing part of exon 3, and internal to a 3.46 kbp HindIII/XbaI fragment, by a 
phosphoglycerate kinase promoter-driven neomycin resistance gene (neo)-selection cassette 
resulted in the deletion of all sequence encoding the 37-amino-acid IAPP peptide. The 
resulting DNA construct was fused with a 5.1 kbp XbaI/SalI fragment and cultured mouse 
129Ola/sv embryonic stem (ES) cells were transfected with the product. ES cells were 
screened for recombinant clones and chimeric mice were generated.  
The screening probe was a 1.5 kbp EcoRI-HindIII genomic DNA fragment containing the 
second exon of the IAPP gene. The deletion of the sequence coding for IAPP in the targeted 
IAPP allele was confirmed using exon 3-specific oligonucleotide probes bp 89-179 and bp 
170-253 of the published mouse IAPP sequence. These probes were radio labeled using 
5’GTTGCTGGAA3’ and 5’CCTAGGGGAC3’, respectively, as primers in the presence of 
[32P]dCTP, unlabelled dATP, dTTP, and dGTP and the Klenow fragment of DNA polymerase 
I. Hybridizations were carried out at high stringency. 
We did not generate the amylin knockout mice ourselves for our studies, but our breeders 
were supplied by Amylin Pharmaceuticals, Inc., USA. The breeder mice were derived from 
frozen embryos of amylin knockout mice of the original mouse strain developed by Gebre-
Medhin. 
 
2.1.2 Animal breeding and housing 
In order to minimize any prenatal and postnatal environmental influences on projection 
development, it was of great importance for the present study to use IAPP+/+ and IAPP-/- 
littermates. For this reason, homozygous amylin knockout mice (provided by Amylin 
Pharmaceuticals, Inc., USA) were crossbred with C57BL/6 wildtype mice (Jackson 
Laboratories, Maine, USA), thus establishing a heterozygous (IAPP+/-) F1 generation. 
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Heterozygous breeding pairs were used to create an F2 generation, which was, according to 
the Mendelian inheritance, expected to comprise 25% IAPP+/+ wildtype (wt), 50% IAPP+/- 
heterozygous (het) and 25% IAPP-/- knockout (ko) mice (Fig.1). 
 
 
Figure 1 Breeding of transgenic mice and expected distribution of genotypes in the F2 
generation.  
C57BL/6 mice were obtained from Jackson Laboratories, USA; IAPP-/- mice from Amylin 
Pharmaceuticals, Inc., USA. 
 
For DiI tracing studies, male ko and wt littermates were used on postnatal day 14 (P14) 
and around postnatal day 60 (±2 days; P60) to investigate the development of projections 
from the AP to the NTS and from the ARH to the PVH, respectively. Male and female 
littermates were used on P60 for immunohistochemistry for the detection of amylin-induced 
c-Fos expression. Animals from litters smaller than five or larger than ten pups were excluded 
from the study in order to minimize the likelihood that differences in individual development 
due to litter size account for the effects characterized in the current study. Experiments were 
in accordance with the guidelines of and approved by the Veterinary Office of the Canton 
Zurich, Switzerland. 
All animals were kept in standard macrolon cages; litters were housed in the same cage 
with their parents until they were used for the experiments or until weaning on P21. The 
breeding pairs and weaned mice had ad libitum access to food (standard pellet chow, #3430, 
Kliba Nafag AG, Gossau, Switzerland) and water. Animals were kept under an artificial 12:12 
h light / dark cycle with lights off at 6 pm. 
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2.2 DiI fiber labeling 
2.2.1 Perfusion and tissue fixation 
2.2.1.1 Material 
• Micro eye scissor (85mm, 3 3/8”, B. Braun medical AG, Tuttlingen, Germany) 
• Micro forceps (Jeweler Type, 0.3mm, angled, 110mm, 4 3/8”, B. Braun Medical 
AG) 
• Canulae (Terumo, 26G x ½”, Leuven, Belgium) 
• Three-way stopcock (B. Braun Medical AG) with flexible infusion tubes 
• Mini-clamp to fix perfusion canula 
• Syringes (Omnifix 1ml, 20ml, Braun Melsungen AG, Melsungen, Germany) 
• 4% paraformaldehyde in sodium phosphate buffer (Tab. 1) 
- Paraformaldehyde purum ≥95.0% (Sigma-Aldrich, Saint Louis MO, USA) 
- Sodium dihydrogen phosphate monohydrate (Sigma-Aldrich) 
- Sodium phosphate dibasic dihydrate (Sigma-Aldrich) 
• 0.9% NaCl 
• Pentobarbital sodium (50mg/ml, Kantonsapotheke Zürich KAZ, Switzerland) 
• Tribromoethanol (Tab. 2) 
- 2,2,2-Tribromoethanol (Sigma-Aldrich) 
- Ter-amyl alcohol-gold label reagent (Sigma-Aldrich) 
- Ethanol 100% 
- 0.7% Saline 
 
Table 1 4% Paraformaldehyde in sodium phosphate buffer 
Stock solution Substance Concentration [g/l]  End concentration [M]  
I NaH2PO4 ⋅ H2O 27.6 0.2 
II Na2HPO4 ⋅ 2H2O 35.85 0.2 
Working Solution: 500ml ddH2O + 40g Paraformaldehyde + 2 pellets of NaOH were stirred and 
heated until complete dissolving, then filtered into 115ml of stock I and 385ml of stock II. The 
pH was adjusted to 7.4 using HCl. 
 
 
Table 2 Tribromoethanol 
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 Preparation 
Stock solution 
100g 2,2,2-Tribromoethanol dissolved in 62.5ml of ter-amyl alcohol-
gold label reagent (Kantonsapotheke Zürich KAZ) 
Working solution 2ml TBEtOH + 8ml EtOH 100% + 90ml NaCl 0.7% 
 
2.2.1.2 Anesthesia and transcardial perfusion 
Adult mice were deeply anesthetized intraperitoneally with pentobarbital sodium 
(200mg/kg). For mouse pups, tribromoethanol (0.15-0.2ml/pup) was used because they are 
extremely sensitive to pentobarbital and the risk of respiratory arrest is much higher in mouse 
pups than in adults. Tribromoethanol provides surgical tolerance within five minutes, good 
analgesia and deep anesthesia for approximately one hour. In addition, respiratory depression 
is lower with tribromoethanol than with pentobarbital, which is crucial for the anesthesia of 
neonatal pups.  
The injection site was paramedian between teats and knee flexure with the needle 
pointing at the contralateral elbow. Loss of the flexor reflex of the hind leg was tested with a 
forceps to confirm anesthetic depth.  
After confirming a deep level of anesthesia, mice were fixed in a dorsal position. The 
skin of the thorax and the abdomen was dissected and an incision was made at the xiphoid 
process. The abdominal wall was cut along the costal arcs without injuring the liver to clearly 
visualize the diaphragm. After removing the diaphragm, the thoracic cavity was opened by 
cutting the ribs and the heart was exposed. A small incision with a micro eye scissor was 
made into the left ventricle to facilitate the insertion of a blunt 26 G canula; after fixing the 
canula with a mini-clamp the right atrium was cut. Exsanguination was then performed by 
infusing a 0.9% NaCl solution into the left ventricle with a hydrostatic pressure of 150cm for 
2 minutes, followed by the perfusion with ice-cold paraformaldehyde solution (PFA) for 6 
minutes. After fixation, the mice were decapitated and the skullcap was quickly removed. 
Brains were immediately transferred into cold PFA and kept for 10 days at 4°C for 
postfixation.  
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2.2.2 DiI Implantation 
2.2.2.1 Material 
• DiI C18 (1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate, 
Molecular Probes, Eugene, OR) 
• Micrometer benchmark (100 x 0.01mm, Pyser-SGI Limited, Kent, UK) 
• Insect pin (Minutien, 0.1mm, Bauer Handels GmbH, Adetswil, Switzerland) 
• Zoom stereomicroscope (Wild M8, Leica Microsystems, Nussloch, Germany) 
• Methylene blue 
• 3 way micromanipulator (SD Instruments, Grants Pass, OR, USA) 
• Dual arm fiber optic illuminator (Intralux® 4000, Volpi AG, Schlieren, Switzerland) 
• Micro forceps (Jeweler Type, 0.3mm, angled, 110mm, 4 3/8”, B. Braun Medical 
AG) 
 
2.2.2.2 Implantation into the AP 
After the brains had been postfixed for 10 days, they were transected at the mid 
rostrocaudal level. The hindbrains were processed directly, while the forebrains were 
embedded in agarose before they were trimmed to expose the implantation site (see below). 
Methylene blue was used to stain and identify morphological structures of the hindbrain. The 
cerebellum was carefully dissected with two micro forceps under a stereomicroscope until the 
area postrema (AP) could be identified. A DiI crystal, which had been selected before and 
checked for size and shape, was then implanted into the AP. Selected crystals had a round, 
symmetric shape and were about 10 and 15 µm in diameter for P14 and P60 mice, 
respectively.  
The crystal was first placed at the intended implantation site on the surface of the AP, 
using a micromanipulator. It was then carefully pushed into the tissue with an insect pin. The 
implantation site was in the center of the dorsal AP surface and the crystal was placed about 
50µm under the surface (Fig. 2 + 3). After implantation, brains were stored in 4% PFA at 
37°C and the tracer was allowed to migrate for 10 days in the dark. 
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Figure 2 Implantation site of DiI crystals 
Brainstem after the removal of the cerebellum and stained with methylene blue.  
Dotted line = AP surface, black dot = implantation site 
 
 
Figure 3 Implantation site of DiI crystals in the AP illustrated in a coronal diagram of 
the brainstem (adapted from Paxinos and Franklin, 2004) 
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2.2.2.3 Implantation into the ARH 
Forebrains had to be embedded in 3% agarose and sliced from caudal to rostral with a 
vibratome (see chapter 2.2.3) until the arcuate nucleus was accessible for implantation. 
During slicing, single sections were collected and evaluated under the stereomicroscope after 
methylene blue treatment to determine bregma positions. Crystals (diameter about 25 µm) 
were then implanted unilaterally in the center of the ARH (Fig. 4), using the same technique 
as in the AP. The tracer was allowed to diffuse for six weeks in the dark at 37°C. 
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Figure 4 Implantation site of DiI crystals in the ARH illustrated in a coronal diagram of 
the forebrain (adapted from Paxinos and Franklin, 2004; image specifications 
corresponding to adult mice) 
A The crystal was implanted along the rostrocaudal axis into the center of the ARH 
B Detail magnification of A (black box); shaded field =ARH, black dot = implantation site 
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2.2.3 Brain slicing 
2.2.3.1 Material 
• Vibratome (Leica VT 1000s, Leica Microsystems) 
• Agarose (#820723, MP Biomedicals, Inc., Solon, Ohio, USA) 
• KPBS buffer (Tab. 3) 
• Multi-well plate 
• Soft paint brush 
• Poly-L-lysine-coated (sigma-Aldrich, Inc.) glass slides (Thermo Scientific, 
microscope slides 76 x 26mm, Menzel GmbH & Co. KG, Braunschweig, Germany) 
• 65% KPBS buffered glycerol 
• Microscopic cover slips (24 x 50mm, Menzel GmbH & Co. KG) 
• Rapid mounting medium (Entellan®, Merck, Darmstadt, Germany) 
 
Table 3 KPBS buffer (0.02M) 
Substance Weight [g] 
KH2PO4 9.7 
K2HPO4 56.6 
NaCl 178.2 
Dissolved in 20.58l ddH2O to final 
concentration of 0.02M 
 
2.2.3.2 Vibratome slicing 
10 days after DiI implantation, hindbrains were embedded in 3% agarose, assuring an 
upright and symmetric position. Forebrains were sectioned after an incubation time of six 
weeks after implantation. After trimming and fixing the agarose blocks with superglue, a 
vibratome was used to cut 80 µm thick coronal sections through the brainstem and the 
hypothalamus. Hindbrains were sliced approximately between bregma -7.08mm and -8.24mm 
and forebrains between bregma -0.46mm and -1.70mm (bregma levels corresponding to adult 
mice, see Fig. 3. + 4.).  
A soft paint brush was used to collect the brain slices, which were kept in KPBS until 
mounting onto poly-L-lysine-coated glass slides. The slices were covered with 65% KPBS 
buffered glycerol before the coverslips were put on the glass slides and fixed with Entellan®. 
Slides were stored at 4°C in the dark to reduce tracer fading. 
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2.2.4 Fluorescence microscopy 
2.2.4.1 Material 
• Fluorescence microscope (Zeiss Axioskop 2, upright epifluorescence microscope, 
Zeiss Co., Oberkochen, Germany) 
• Fluorescence filter set 43 (Zeiss Co., excitation BP 545/25nm, emission BP 
605/70nm) 
• Microscopy digital camera (Axiocam HS, Zeiss Co.) 
 
2.2.4.2 Microscopy 
Fluorescence microscopy was used to assess successful crystal implantations and 
symmetric diffusion of the tracer. This was important to eliminate variation in fiber density 
due to abnormal diffusion or a loss of the crystal during the incubation period. Any slides that 
did not meet the following criteria were excluded from further analysis. 
 
• Successful crystal implantation: Some crystals got lost during the incubation time or 
were implanted too superficially. For this reason, it was first checked whether the 
crystal was implanted deeply enough into the tissue (see Fig. 3 + 4).  
 
• Symmetric crystal implantation: The symmetry of implantations was only checked in 
the AP, where the crystal had to be implanted exactly in the midline in order to 
diffuse symmetrically. As the implantation in the ARH was unilateral, it was not 
necessary to confirm symmetry for the entire ARH. 
 
• Restricted tracer diffusion area: In addition to migrating along fibers, the tracer also 
diffused unspecifically into the surrounding tissue. This unspecific signal had to be 
restricted to the AP and the ARH, respectively. 
 
• Intact tissue: Slices with damaged tissue in the AP/NTS or ARH/PVH were excluded 
from further analysis.  
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Figure 5 Fluorescence microscopic image showing an example of a successful 
implantation with symmetric and restricted tracer diffusion area 
AP = Area postrema, NTS = Nucleus of the solitary tract, dotted line = boundary of the AP 
 
The fluorescence microscope was equipped with an adequate filter set (fluorescence filter 
set 43, Zeiss Co.) for the visualization of DiI fluorescence. Excitation and emission spectra of 
DiI and the filter set are shown in Fig. 6. A digital camera was used to take pictures in 
different magnifications. 
 
 
Figure 6 Spectral range of DiI tracer and filter set 43 (adapted from Zeiss Co.) 
Red curve = excitation (551nm); green curve = emission (565nm) of DiI tracer 
Blue area = excitation (BP 545/25nm); orange area = emission (BP 605/70); grey area = beamsplitter (FT 
570nm) of filter set 43 
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2.2.5 Confocal laser microscopy 
2.2.5.1 Material 
• Confocal laser microscope (Leica SP2 AOBS, Leica Microsystems, Wetzlar, 
Germany) 
• 63x glycerol objective (Leica, HCX PL APO lbd. BL 63x 1.3 CORR) 
• 20x multi objective (Leica, HC PL APO lbd. BL 20x 0.7 IMM/CORR) 
2.2.5.2 Scanning 
DiI-labeled fibers of one section per brain were scanned with a confocal laser 
microscope. Images of the NTS region (Fig. 7) and the PVH were collected approximately at 
bregma -7.8 and bregma -0.98 (corresponding to adult mice), respectively, to analyze 
projections from the AP to the NTS or from the ARH to the PVH. Image stacks consisted of 
75 single images with a thickness of 0.8 µm each. 
For excitation, a Helium-Neon laser with a wavelength of 543nm was used; emission was 
detected by PMT2 between 570 and 620nm. Further settings were adjusted as follows: 
 
• Laser  HeNe 543nm; 83% 
• Airy 1 pinhole 232.43µm 
• Scan averaging 6 
• Series  a 60µm thick block was scanned with a 0.8µm step length 
• Gain   adjusted manually, approximately 600 
• Offset  adjusted manually, approximately -10 
 
Gain and offset were adjusted manually depending on the individual signal intensity to 
optimize the signal:noise ratio. 
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Figure 7 Fluorescence microscopic image illustrating the confocal scanning area in the 
NTS 
AP = Area postrema; NTS = Nucleus of the solitary tract; white box = scanning area 
 
2.2.6 Quantitative analysis 
Image stacks were imported into the analysis application of the image analysis software 
(Imaris Version 6.4.0, Bitplane, Zurich, Switzerland). After three-dimensional reconstruction 
and volume rendering, the filament tracer application was used to analyze fiber density. 
Briefly, an autopath algorithm was used to generate filaments by connecting starting and seed 
points based on local intensity contrast. The largest diameter of starting points was set to 8µm, 
the thinnest of seed points to 0.931µm, spine detection was disabled and the signal range was 
adjusted manually by thresholding. Fibers were then skeletonized to a diameter of one pixel to 
allow the software to calculate different parameters, among them the total fiber length in the 
entire volume of the image stack (3.4x10-3mm3). 
 
2.3 Immunohistochemistry 
Immunohistochemical studies for c-Fos and calcitonin receptors were conducted in IAPP-
/- and IAPP+/+ animals around postnatal day 60. For the c-Fos study, adult male mice were 
fasted for twelve hours before receiving a subcutaneous injection of 50µg/kg amylin 
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(Bachem, Bubendorf, Switzerland). The animals were perfused two hours after the injection. 
Due to a lack of male IAPP-/- mice, untreated adult female mice were used for the CTR 
studies. They were neither fasted nor pretreated in any way. 
 
2.3.1 Perfusion and tissue fixation 
Perfusion for immunohistochemistry was conducted as described in chapter 2.2.1, with a 
few adaptations made in the protocol. Exsanguination was performed using 0.1M phosphate 
buffer (PB; Tab. 4), and the pH level of PB and PFA was set to 7.2 instead of 7.4. After 
postfixation in PFA for two hours at 4°C, brains were left for two days in 20% sucrose, 
dissolved in 0.1M PB, for cryoprotection. 
 
Table 4 0.1M phosphate buffer 
Stock solution Substance Concentration [g/l]  End concentration [M]  
I NaH2PO4 ⋅ H2O 27.8 0.2 
II Na2HPO4 ⋅ 2H2O 35.6 0.2 
95ml of stock I and 405ml of stock II were stirred and diluted with 500ml ddH2O to get 1l of 
0.1M PB. After cooling the solution to 4°C, pH level was set to 7.2 using HCl. 20ml of 0.1M PB 
and 4g of sucrose per brain were used for the 20% sucrose solution. 
 
2.3.2 Brain slicing 
2.3.2.1 Materials 
• Cryostat (Leica CM 3050 S, Leica Microsystems) 
• Forceps (B. Braun Medical AG) 
• Freezing medium (Tissue Freezing Medium®, Leica Microsystems) 
• Adhesive glass slides (Superfrost® Plus, Menzel GmbH & Co. KG) 
• Dry ice 
• Hexane  
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2.3.2.2 Slicing 
After cryoprotection in sucrose solution the brains were rinsed with buffer solution to 
wash off the sucrose. They were transected at the mid rostrocaudal level before putting them 
into hexane on dry ice for three minutes. Using a cryomicrotome, the AP/NTS region of 
frozen brains was sliced into two series of 20µm sections, using adhesive glass slides to 
collect them. The slides were stored at -20°C until further processing. 
2.3.3 Immunohistochemistry for c-Fos 
2.3.3.1 Materials 
• Phosphate buffered saline (Tab. 5) 
• Triton® X-100 (Sigma-Aldrich) 
• Normal goat serum (Jackson Laboratories) 
• Avidin/Biotin blocking kit (Vector Laboratories, Burlingame, USA) 
• Primary antibody (anti-c-Fos Rabbit pAb (Ab-5), Merck) 
• Secondary antibody (biotinylated goat anti-rabbit IgG (H+L), Vector Laboratories) 
• DAB (3,3’-diaminobenzidine tetrahydrochloride hydrate, 97%, Sigma-Aldrich) 
• Nickel(II) chloride Hexahydrate (Sigma-Aldrich) 
• Cobalt(II) chloride Hexahydrate (Merck) 
• ABC kit (Vectastain®, Vector Laboratories) 
• Ethanol 
• Xylol 
• Rapid mounting medium (Entellan®, Merck) 
 
Table 5 10x Phosphate buffered saline 
Substance Concentration [g/l] End concentration [mM] 
NaCl 80 137 
KCl 2 1.47 
Na2HPO4 18.1 7.81 
KH2PO4 2.4 2.68 
For working solution (1x PBS), 1l of 10x PBS was diluted with 9l ddH2O and the pH 
level was adjusted to 7.4 using HCl. 
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2.3.3.2 Protocol 
The slides were air-dried for one hour before washing them in 0.1% PBST (0.1ml 
Triton® in 100ml PBS) for ten minutes. To block unspecific antibody binding, a two hour 
incubation in blocking solution (1.5% in 0.3% PBST) was conducted, followed by another 
wash in 0.1% PBST (3x10 minutes). Slides were then incubated in 1:5000 primary antibody 
at 4°C for 36 to 48 hours. 
After washing (5x10 minutes), incubation with the secondary antibody (1:400) for 90 
minutes and another wash step (3x10 minutes) followed before incubating the slides with the 
avidin-biotin complex for one hour. For visualization of the antibody binding, slides were 
incubated in a DAB intensifying solution (PBS with 0.02% H2O2, 0.08% NiCl and 0.01% 
CoCl) for three minutes, followed by a final washing step (3x5 minutes) and dehydration in 
graded alcohols (50-100%) and xylol. Slices were finally coverslipped with Entellan®. 
c-Fos positive cells in the AP and the NTS were evaluated under a light microscope. Four 
representative and corresponding sections per animal were quantified and averaged to 
compare c-Fos activation in ko and wt animals. 
 
2.3.4 Immunohistochemistry for calcitonin receptors 
2.3.4.1 Material 
• Phosphate buffered saline (Tab. 5) 
• Triton® X-100 (Sigma-Aldrich) 
• Normal donkey serum (Jackson Laboratories) 
• Primary antibody (Rabbit anti-CTR, kindly provided by Dr. P. Wookey, Melbourne) 
• Secondary antibody (Alexa Fluor® 555 donkey anti-rabbit IgG (H+L), Invitrogen, 
Basel, Switzerland) 
• Citifluor™ (Citifluor Ltd., London, UK) 
• Rapid mounting medium (Entellan®, Merck) 
 
2.3.4.2 Protocol 
The slides were air-dried and washed as for c-Fos before blocking unspecific antibody 
binding with 3% normal donkey serum in 0.3% PBST. After washing in PBS (2x10 minutes) 
and 0.1% PBST (10 minutes), the slides were incubated in 1:1000 primary antibody at 4°C for 
36 to 48 hours. 
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The antibody was removed by washing in PBS (2x10 minutes) and PBST (10 minutes) 
previous to the incubation in 1:222 secondary antibody for 80 minutes. After the final wash in 
PBST (10 minutes) and PBS (2x10 minutes), the slices were covered with citifluor and the 
coverslips fixed with Entellan®. 
 
2.3.4.3 Quantitative analysis 
The AP of CTR stained sections was scanned with the confocal laser microscope as 
described in 2.2.5. The settings were slightly changed for emission detection, as the spectral 
range of DiI and Alexa 555 are not identical (Fig. 8). Emission was detected between 580 and 
650nm; gain and offset were also adjusted manually. Image stacks contained 23 single images 
with a thickness of 0.8µm, i.e. a total of 18.4µm. 
 
Figure 8 Spectral range of Alexa 555 (adapted from Zeiss Co.) 
Light blue = excitation (553nm); dark blue = emission (568nm) of Alexa 555 
 
The stacks were also three-dimensionally reconstructed and analyzed with Imaris 6.4.0 
(Bitplane, Zurich, Switzerland). The surface application was used to create an artificial solid 
object based on gray value range and manual thresholding (Fig. 9). The total volume of all 
stained objects (“receptor density”) in a standardized volume of the AP (0.184x10-3mm3) was 
calculated for four sections per animal and averaged to compare CTR expression between ko 
and wt animals. 
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Figure 9 Confocal image stacks of the area postrema after immunohistochemical 
processing for calcitonin receptors 
A Representative three-dimensional reconstruction of confocal image stacks 
B Quantification area containing the artificial surface corresponding to CTR density (white box) 
 
2.4 Genotyping 
Because all animals used in the present study were the offspring of heterozygous 
breeding pairs, the genotype was not known at birth. Therefore, biopsies had to be taken in 
order to extract the DNA, amplify it by PCR and analyze by electrophoresis. Mouse pups 
were marked by toe amputation on postnatal day 6 or 7. Toes were clipped with a scalpel, 
collected in labeled 1.5ml Eppendorf tubes and stored at -20°C until analysis. 
2.4.1 DNA extraction 
2.4.1.1 Material 
• Thermal shaker 
• Solubilization buffer (Tab. 10) 
• Proteinase K (Promega Co, Madison, USA) 
• Tail salt solution (Tab. 11) 
• Isopropanol 60% 
• Ethanol 70% 
• Tris-EDTA buffer (Tab. 12) 
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Table 6 Solubilization buffer (50ml) 
Substance Stock concentration Amount [g] Volume [ml] End concentration [M] 
SDS 10 % 0.5 5 1 % 
Sodium acetate 3M 1.23 5 0.3M 
EDTA 50mM 0.019 1 1mM 
Tris-HCl (pH 6.8) 1M 0.061 0.5 10mM 
Fill up to 50 ml with aqua dest 
 
Table 7 Tail salt solution (50ml) 
Substance Concentration [g/50ml] End concentration [M] 
NaCl 12.3 4.21 
KCl 2.3 0.63 
Fill up to 45 ml with Tris-HCl (10mM), adjust pH to 8.0, fill up to 50 ml 
 
Table 8 TE buffer (100ml) 
Substance 
Stock 
concentration 
Amount [g] Volume [ml] 
End concentration 
[M] 
Tris-HCl (pH 8.0) 1M 0.012 0.1 1mM 
EDTA 50mM 0.037 2 1mM 
 
2.4.1.2 Protocol 
First, 500µl of solubilization buffer and 50µl proteinase K were added to the specimens 
before incubating them for 30 minutes at 55°C with 950 rpm on a thermal shaker. This step 
served the lysis of cells and the degradation of DNA-associated proteins. For the precipitation 
of proteins, 200µl of tail salt solution were added for another incubation with the same 
parameters. The tubes were centrifuged for 10 minutes at 4°C with 13000rpm and the 
supernatant was transferred into new Eppendorf tubes. The DNA was precipitated by mixing 
the supernatant with 500µl of 60% isopropanol, followed by centrifugation for 30 minutes at 
4°C with 15000rpm. After decanting the supernatant, the pellet was washed with 500µl ice-
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cold 70% ethanol and centrifuged again for 15 minutes at 4°C with 13000rpm. The 
supernatant was carefully removed before the pellet was air-dried for about 20 minutes. 
Finally, the pellet was resuspended overnight at room temperature with 100µl of TE buffer. 
Alternatively, it was dissolved by an incubation for 2 hours at 55°C with 400rpm on the 
thermal shaker. 
2.4.2 DNA amplification 
2.4.2.1 Materials 
• PCR thermocycler 
• ddH2O 
• Green PCR buffer (Promega Co., Madison, USA) 
• MgCl2 (Promega Co.) 
• dNTP’s (Promega Co.) 
• Primer Nr. 206 (ko) 
• Primer Nr. 207 (ko) 
• Primer Nr. 208 (wt) 
• Primer Nr. 209 (wt) 
• Go-Taq® Flexi DNA Polymerase (Promega Co.) 
• DNA template 
2.4.2.2 Protocol 
All substances of the mastermix (Tab. 14) were pipetted into a 1.5ml Eppendorf tube, 
which had been kept on ice. The mix was vortexed and quickly centrifuged at 4°C before 24µl 
per sample were transferred into sterile 200µl tubes. 1µl of the genomic DNA template to 
analyze was added to a total volume of 25µl. The tubes were placed in a PCR thermocycler 
with the following program (Tab. 15): denaturation at 94°C for one minute, followed by 10 
cycles of melting at 92°C for 30s, annealing at 65°C for 30s and synthesis at 72°C for 30s; 
followed by 25 cycles of melting at 92°C, annealing at 62°C for 30s and synthesis at 72°C for 
30s; followed by a final extension step at 72°C for 5 minutes. The first 10 cycles served as a 
touch down to avoid unspecific annealing and therefore unspecific DNA amplification. 
Samples were kept at 4°C until separation. 
see Tab. 13 for genotype-specific primers 
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Table 9 Primers 
Primer Sequence (5’ – 3’) 
Length 
[mer] 
Tm [°C] Location 
Product 
size [bp] 
206 CTTGGGTGGAGAGGCTATTC 20 58.7°C/57.5 
207 CACAGCTGCGCAAGGAAC 18 61.8°C/57.1 
Chromosome 6 200 
208 GTAGCAACCCTCAGATGGAC 20 57.2°C/57.5 
209 GAGGACTGGACCAAGGTTGT 20 59.0°C/57.5 
Chromosome 6 107 
 
Table 10 Mastermix 
Volume [µ l] 
Substance 
1 5 10 
Concentration 
ddH2O 14.375 71.875 143.75  
Green PCR-Buffer (5x)  5.0 25 50  
MgCl2 25 mM  2.0 10 20  
dNTP’s 2.5 mM each  0.5 2.5 5  
Primer Nr. 206 ko 0.5 2.5 5 10 µm 
Primer Nr. 207 ko 0.5 2.5 5 10 µm 
Primer Nr. 208 wt 0.5 2.5 5 10 µm 
Primer Nr. 209 wt 0.5 2.5 5 10 µm 
Go-Taq Flexi Polymerase 5u/µl  0.125 0.625 1.25 0.625 u 
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Table 11 PCR conditions 
Cycles Time Temperature Process step 
1 1’ 94°C Start 
30’’ 92°C Melting 
30’’ 65°C Annealing 10 
30’’ 72°C Synthesis 
30” 92°C Melting 
30” 62°C Annealing 25 
30” 72°C Synthesis 
1 5’ 72°C Synthesis 
 ∞ 4°C Hold 
 
2.4.3 DNA separation 
2.4.3.1 Material 
• Agarose (#820723, MP Biomedicals, Inc., Solon, Ohio, USA) 
• Ethidiumbromide 
• DNA ladder (100bp, Fermentas International Inc., Canada) 
• TAE buffer (Tab. 16) 
• Electrophoresis chamber 
 
Table 12 50x TAE buffer 
Substance Concentration [g/l] End concentration [M] 
EDTA 18.61 0.05 
Tris-HCL pH 8.0 242 2 
Acetic acid 57.1ml 2 
Working solution is 1x TAE 
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2.4.3.2 Protocol 
In a microwave, 2g of agarose were heated in 100ml 1x TAE buffer until completely 
dissolved. The solution was left to cool for a few minutes before 2µl of ethidium bromide 
were added and mixed in carefully without creating bubbles. Ethidiumbromide intercalates 
with the DNA and fluoresces when exposed to UV light; for these reasons it is used to 
visualize PCR products in the agarose gel.  
The gel was poured into the electrophoresis chamber and before it had entirely cooled 
down, the comb was inserted. If any air bubbles had been created, they were removed with a 
pipette tip. The chamber was filled with 1x TAE buffer until the gel was covered with 3 to 
5mm of the buffer solution. 
After the comb had been removed, 12µl of each sample were loaded besides a molecular 
DNA weight marker (100bp DNA ladder) for size estimation. Furthermore, representative 
samples and mastermix without DNA template were loaded as positive and negative controls. 
Electrophoresis was run with a voltage of 140V for about 40 minutes; afterwards the gel was 
exposed to UV light for documentation of the amplicons (Fig. 10). The sizes of amplicons 
were expected as follows for the different genotypes: 
 
Table 13 Expected bands 
Genotype Primers Amplicon size 
 
206/207 200bp 
-/- knockout 
208/209 No product 
 
206/207 200bp 
+/- heterozygous 
208/209 107bp 
 
206/207 No product 
+/+ wildtype 
208/209 107bp 
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Figure 10 Agarose gel after electrophoresis showing the amplicons 
M = molecular DNA marker; +/+ = wildtype; +/- = heterozygous; -/- = knockout; ntc = no template 
control; 1-8 = test specimens: 1, 3, 4, 5, 6 = heterozygous; 2, 7, 8 = wildtype 
 
2.5 Statistical analysis 
All data are presented as means ± SEM. Statistical significance was determined by 
parametric t-test of data with normal distribution (Kolmogorov-Smirnov normality test) using 
Prism Version 5.0a for Mac OS X (GraphPad Software Inc., San Diego, CA, USA). A p-value 
< 0.05 was considered statistically significant. 
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3 Results 
3.1 Neurotrophic effects of amylin 
3.1.1 Fiber density in the NTS on P10, P14 and P60 
In a previous study, we found a significantly reduced fiber density in the NTS of P10 
IAPP-/- mouse pups compared to IAPP+/+ littermates (Fig. 1). Interestingly, there was only a 
tendency towards a reduction in P14 IAPP-/- mice, which did not reach statistical significance 
compared to their wildtype littermate controls (results not shown). Because of the relatively 
low number of animals with the appropriate genotype in this experiment, male and female 
littermates had been combined to final group sizes of 5 and 6 for IAPP-/- and IAPP+/+ mice, 
respectively.  
To eliminate a possible influence of gender differences on the development of AP to NTS 
projections, we excluded all female mice from the previous study and included additional 
male animals in the present study. This resulted in a total number of six male P14 IAPP-/- and 
five male IAPP+/+ mice, respectively. The results were comparable to our previous data; in 
other words, we did not observe a significant difference in total fiber length between IAPP-/- 
(7707 ± 1489) and IAPP+/+ mice (11800 ± 3456); the P value of p = 0.3 was similar as before. 
When comparing the male wildtype mice between P10 and P14, total fiber length differed 
significantly between P10 IAPP+/+ and P14 IAPP+/+ male mouse pups, supporting the 
hypothesis of neural remodeling processes during this time window (Fig. 1). Hence, the lack 
of significant difference in total fiber length between P14 IAPP-/- and IAPP+/+ mice was 
mainly due to a marked reduction in fiber density in the wildtype controls. The fiber density 
of IAPP-/- mice however did not significantly change from P10 to P14 and P60. 
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Figure 11 Total fiber length in the NTS of male P10, P14 and P60 IAPP+/+ and IAPP-/- 
mice (P10 data from A. Hermann) 
The total fiber length in a volume of 3.4x 10-3mm3 on P10 was significantly lower in IAPP-/- mice (10460 ± 
3341) compared to wildtype littermates (23160 ± 3265) (p < 0.05); there was also a significant decrease in 
wildtype IAPP+/+ males between P10 and P14 (p < 0.05). Fiber length in IAPP-/- mice on P60 was similar to 
IAPP+/+ animals but the data are preliminary (n=1 in the wildtype controls). In IAPP-/- mice, the fiber 
density did not significantly change between P10, P14 and P60.All data are expressed as mean ±SEM; *p < 
0.05; n.s. = not significant 
 
To investigate a possible impact of amylin deficiency on the AP/NTS neuroanatomy of 
adult mice, tracing studies with P60 mice were conducted. Due to temporary breeding 
problems, the number of animals that were analyzed (i.e. after the exclusion of animals with 
unsuccessful implantations) was relatively low. P60 IAPP-/- (11040 ± 750, n=6) animals 
showed a fiber density similar to the only P60 IAPP+/+ animal (13099) included in the 
experiment. Fiber density was also similar to P14 IAPP+/+ (11800 ± 3456, n=5) mice. Further 
investigation is required before definite conclusions can be drawn about the consequences of 
amylin deficiency for the neuroanatomy of adult mice. 
Typical examples for the density of projections from the AP to the NTS in IAPP-/- and 
IAPP+/+ mice of different ages are shown in Figures 2, 3 and 4. 
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Figure 12 Representative confocal image stacks and created fiber skeleton of the NTS in 
P10 mice (images from A. Hermann) 
A+B Three-dimensionally reconstructed confocal image stacks of the NTS region of male P10 IAPP+/+ and 
IAPP-/- littermates 
C+D Skeletonized fibers corresponding to the confocal images A+B and used for the quantification of total 
fiber length 
A B 
C D 
IAPP+/+ 
IAPP+/+ IAPP-/- 
IAPP-/- 
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Figure 13 Representative confocal image stacks and created fiber skeleton of the NTS in 
P14 mice 
A+B Three-dimensionally reconstructed confocal image stacks of the NTS region of male P14 IAPP+/+ and 
IAPP-/- littermates 
C+D Skeletonized fibers corresponding to the confocal images A+B and used for the quantification of total 
fiber length 
 
IAPP+/+ 
IAPP+/
+ 
IAPP-/- 
IAPP-/- 
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Figure 14 (preliminary data) Representative confocal image stacks and created fiber 
skeleton of the NTS in P60 mice 
A+B Three-dimensionally reconstructed confocal image stacks of the NTS region of male P60 IAPP+/+ and 
IAPP-/- littermates 
C+D Skeletonized fibers corresponding to the confocal images A+B and used for the quantification of total 
fiber length 
IAPP+/+ 
IAPP+/+ IAPP-/- 
IAPP-/- 
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3.2 c-Fos expression and calcitonin receptor density in the AP 
3.2.1 c-Fos expression in the AP/NTS region of adult mice 
To investigate signal transduction from the AP to the NTS in adult IAPP+/+ and IAPP-/- 
mice, an immunohistochemical study for amylin-induced c-Fos expression was performed. 
There was no significant difference in the number of c-Fos positive cells 120 min after amylin 
injection between male P60 IAPP+/+ (n=3) and IAPP-/- (n=5) mice either in the AP (wt: 70 ± 7; 
ko: 57 ± 4) or in the NTS (wt: 38 ± 1; ko: 38 ± 3) (Fig. 5 + 6).  
 
 
Figure 15 Number of c-Fos expressing cells in the AP and NTS of male P60 IAPP+/+ and 
IAPP-/- mice 120 min after amylin injection (50µg/kg SC) 
There was no significant difference in the number of c-Fos positive cells in either the AP or the NTS of 
IAPP+/+ and IAPP-/- mice. All data are expressed as mean ±SEM 
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Figure 16 c-Fos expression in the AP and NTS of male P60 IAPP+/+ (A) and IAPP-/- mice 
(B) after amylin injection 
NTS = nucleus of the solitary tract 
 
i re  c- s e ressi  i  t e  a   f ale  I +/+ ( ) a  I -/- ice 
( ) after a li  i jecti  
S  nucleus of the solitary tract 
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3.2.2 Calcitonin receptor density in the AP of adult mice 
The density of calcitonin receptors in the AP of female P60 IAPP+/+ (n=4) and IAPP-/- 
(n=3) mice was determined by immunohistochemistry with antibodies specific against the 
CTR protein. IAPP-/- animals expressed a higher density of CTR in the AP than IAPP+/+ 
animals (6201 ± 1746 vs. 2610 ± 707, respectively), however the difference failed to reach 
statistical significance (p = 0.086) (Fig. 7 + 8). 
 
 
Figure 17 CTR density in the AP of female P60 IAPP+/+ and IAPP-/- mice 
CTR expression in the AP was higher in IAPP-/- animals, but the difference was not statistically significant.  
All data are expressed as mean ±SEM; n.s. = not significant 
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Figure 18 Representative confocal image stacks of the AP and created artificial surfaces  
A+B Three-dimensionally reconstructed confocal image stacks of the AP of female P60 IAPP+/+ and 
IAPP-/- mice 
C+D Artificial surface corresponding to the confocal images A+B and used for the quantification of 
CTR density 
 
C 
 
D 
 
A 
  
B 
IAPP+/+ IAPP-/- 
IAPP+/+ IAPP-/- 
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3.3 Neurotrophic effects of leptin in the AP 
3.3.1 Fiber density in the NTS on P14 
For DiI tracing studies in leptin-deficient ob/ob mice, Dr. S. Bouret kindly provided us 
with perfused brains of leptin-deficient ob/ob and control mice. The experiments were 
conducted with male wildtype (n=6) and ob/ob (n=7) littermates on postnatal day 14 (P14).  
The fiber density in the NTS (expressed as total fiber length in a volume of 3.4 x 10-
3mm3) was significantly reduced in P14 ob/ob mice compared to their wildtype littermates. 
The total fiber length was 14910 ± 1574µm in wildtype mouse pups versus 9833 ± 1040µm in 
ob/ob animals (p<0.05) (Fig. 9).  
A typical example of the reduced density of projections from the AP to the NTS in ob/ob 
mice is shown in Figure 10. 
 
 
Figure 19 Total fiber length in the NTS of male P14 ob/ob and wildtype mouse pups 
The total fiber length in a volume of 3.4x 10-3mm3 was significantly lower in ob/ob mice compared to 
wildtype littermates. All data are expressed as mean ±SEM: **p<0.05 
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Figure 20 Representative confocal image stacks and created fiber skeleton of the NTS 
A+B Three-dimensionally reconstructed confocal image stacks of the NTS region of male P14 wildtype 
and ob/ob littermates 
C+D Skeletonized fibers corresponding to the confocal images A+B and used for the quantification of total 
fiber length 
 
3.3.2 Long projections to other brain regions 
The DiI tracer did not only label fibers from the AP to the NTS, but also projections to 
other brain regions. In all DiI-labeled brains of ob/ob and wildtype mice, large bilateral 
projections emerging ventrolaterally from the NTS were detected (Fig.11), which is similar to 
our previous findings in amylin-deficient IAPP-/- and wildtype IAPP+/+ control mice. 
 
 
wt 
wt ob/ob 
ob/ob 
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Figure 21 Fluorescence microscopic images of large projections outside the NTS in male 
P14 ob/ob and wildtype mice 
A Low magnification of projections emerging ventrolaterally from the NTS (white box = magnification 
in B + C); AP = area postrema, NTS = nucleus of the solitary tract 
B+C High magnification of these projections in wt and ob/ob littermates 
 
These projections have previously been described in anterograde tracing studies and 
terminate to some extent in the nucleus ambiguus, before ascending to the parabrachial 
nucleus (Shapiro and Miselis 1985; van der Kooy and Koda 1983). We evaluated the fiber 
density of these projections semi-quantitatively with a ranking from 1-3, which revealed a 
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higher fiber density in ob/ob mice compared to wildtypes. Data analysis with the chi-square 
test for trend showed statistical significance (p < 0.05) (Fig. 12). 
 
 
Figure 22 Semi-quantitative analysis of projections outside the NTS in male P14 ob/ob 
mice and wildtype littermates 
Ob/ob mice showed a tendency towards  lower fiber content in a semi-quantitative ranking from 1 to 3.  
Analyzed by chi-square test for trend; *p < 0.05 
 
3.4 Establishment of ARH implantations 
It was the aim of the last part of the current study to establish the DiI tracing for the 
detection of ARH-PVN projections as described by Bouret et. al. (Bouret et al. 2004b). Using 
this approach, first studies were conducted to characterize the influence of amylin deficiency 
on the development on these neuronal projections. Our experiments showed that a crystal size 
of 25µm was most appropriate for P14 IAPP+/+ and IAPP-/- mice in order to keep the 
unspecific tracer diffusion restricted to the ARH (Fig. 13). 
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Figure 23 Fluorescence microscopic image of DiI implantation site in the ARH 
ARH = arcuate nucleus of the hypothalamus, 3V = third ventricle 
 
Because we first had to establish this method in our laboratory, the number of analyzable 
slices is not yet sufficient for statistical analysis; nonetheless, it was very interesting to note 
that male P14 IAPP-/- mice showed a tendency towards a reduction in total fiber length 
compared to IAPP+/+ littermates (Fig. 14 + 15), similar to previous observations comparing 
leptin-deficient ob/ob mice and wildtype controls. 
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Figure 23 Fluorescence microscopic image of DiI implantation site in the ARH 
ARH = arcuate nucleus of the hypothalamus, 3V = third ventricle 
 
Because we first had to establish this method in our laboratory, the number of analyzable 
slices is not yet sufficient for statistical analysis; nonetheless, it was very interesting to note 
that male P14 IAPP-/- mice showed a tendency towards a reduction in total fiber length 
compared to IAPP+/+ littermates (Fig. 14 + 15), similar to previous observations comparing 
leptin-deficient ob/ob mice and wildtype controls. 
 
 
 
Figure 24 Total fiber length in the PVH of male P14 IAPP-/- and IAPP+/+ mouse pups 
 
Figure 24 Total fiber length in the PVH of male P14 IAPP-/- and IAPP+/+ mouse pups 
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Figure 25 Representative confocal image stacks and created fiber skeleton of the PVH 
A+B Three-dimensionally reconstructed confocal image stacks of the PVH region of male P14 IAPP-/- and 
IAPP+/+ littermates 
C+D Skeletonized fibers corresponding to the confocal images A+B and used for the quantification of total 
fiber length 
IAPP+/+ 
IAPP+/+ 
IAPP-/- 
IAPP-/- 
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4 Discussion 
The aim of the present study was to further characterize the neurotrophic effects of 
amylin and leptin on the development of neuronal projections in the CNS. The neurotrophic 
effects of leptin on projections from the arcuate nucleus of the hypothalamus (ARH) to other 
hypothalamic regions, namely the paraventricular nucleus (PVH), the lateral hypothalamic 
area (LHA) and the dorsomedial nucleus (DMH), have recently been demonstrated by axonal 
projection labeling (Bouret et al. 2004b). Our hypothesis that amylin has similar effects on the 
development of projections from the area postrema (AP) to the nucleus of the solitary tract 
(NTS) was encouraged by studies demonstrating trophic effects of amylin on the kidney 
(Harris et al. 1997; Wookey et al. 1998), pancreas (Karlsson and Sandler 2001) and bone 
tissue (Cornish et al. 2001; Cornish et al. 1995).  
 
Our group investigated this hypothesis in a previous study by using and adapting the DiI 
tracing method described by Bouret et al. (2004). We found a reduced fiber density in IAPP-/- 
compared to IAPP+/+ mouse pups on P10, which provided strong evidence of a neurotrophic 
effect of amylin on AP-NTS projections. Fibers on P14 were also reduced, but not statistically 
significant, and there was an overall tendency towards lower fiber density on P14 compared to 
P10. However, in our previous study only a low number of animals were available, including 
males and females, which did not permit gender-specific data analysis. For this reason, we 
collected additional data of male P14 pups in the present study, which allowed us to analyze 
and compare the data specifically in male mice.  
Overall and consistent with the previous preliminary data, our results indicate that P14 
male mice of both genotypes have a similar fiber density in respect to their AP to NTS 
projections. We still observed a tendency towards lower fiber density in male P14 IAPP-/- 
compared to IAPP+/+ mice, but the effect was not significant. Hence, the clear and significant 
difference in fiber density between IAPP-/- and IAPP+/+ P10 mice seems to wane, mainly 
because of a reduction of fiber density in the wildtype mice between days P10 and P14. In 
other words, the reduction of fibers in male IAPP+/+ mice from P10 to P14, which was 
observed in the first study, reached statistical significance due to the additional data. This 
provides additional evidence for regressive neuronal remodeling processes in the AP-NTS 
projections of IAPP+/+ mice between P10 and P14. Although our previous combined data for 
both genders yielded a similar outcome for P14 animals, it remains to be investigated 
specifically whether female mice display generally lower AP-NTS fiber densities. This is at 
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least suggested by our previous gender-specific data of P10 mice, although inclusion of more 
animals is required to further support this assumption. 
 
Feeding studies in adult IAPP+/+ and IAPP-/- mice showed no difference in basal food 
intake between genotypes (Gebre-Medhin et al. 1998a). In addition, recent studies from our 
group showed a similar sensitivity of IAPP+/+ and IAPP-/- animals to the eating inhibitory 
effects of exogenous amylin (Theis, 2009). These data indicate that despite the 
neuroanatomical deficits in early postnatal IAPP-/- mice, this defect may not result in 
functional insensitivity to the effect of amylin. 
We were therefore interested in the consequences of amylin deficiency on the 
neuroanatomy of adult mice. This was investigated using the same axonal labeling approach 
as for mouse pups. Furthermore, we wanted to determine a possible impact of amylin 
deficiency and its impact on brain neuroanatomy on signal transduction in the AP/NTS region 
of adult mice using c-Fos expression as a neuronal activation marker, and on calcitonin 
receptor density in the AP. 
Our tracing studies showed that there was no significant change in fiber density of IAPP-/- 
animals from P10 and P14 to P60. A similar comparison for IAPP+/+ mice was not yet 
possible because the group of adult IAPP+/+ mice only comprised one animal due to temporary 
breeding problems; hence, these data have to be considered preliminary. Under the 
assumption that this animal is representative for P60 male IAPP+/+ mice in general, we would 
have to conclude that there is no difference in fiber density between adult IAPP-/- and IAPP+/+ 
animals on P60. This would in principle be consistent with the data on P14. Additionally, 
there was no indication for a further decrease in fiber density for AP to NTS projections in 
male IAPP+/+ mice between P14 and P60. 
The density of CTR was higher in the AP of IAPP-/- mice compared to wildtype controls; 
the difference was not yet significant but very close to statistical significance. The non-
significant outcome has to be interpreted cautiously based on the current group size. An 
increased CTR density in IAPP-/- mice is in principle consistent with the assumption that 
hormone receptors show a compensatory upregulation in hormone-deficient animal models. 
This phenomenon has been shown in the brains of ob/ob mice, which is probably a result of 
the lack of inhibition by leptin binding to its receptors (Huang et al. 1997). We speculate that 
a similar mechanism may be responsible for the high density of CTR, as one of the two main 
components of functional amylin receptors, in the AP of IAPP-/- mice, because autoregulatory 
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receptor-ligand interactions have already been described for calcitonin receptor-like receptors 
(Kuwasako et al. 2000). 
Finally, we analyzed the signal transduction from the AP to the NTS by c-Fos 
immunocytochemistry in adult IAPP-/- mice. Consistent with the findings in adult IAPP-/- mice 
that showed no difference in fiber density compared with wildtype controls, there was no 
significant difference in the number of c-Fos expressing cells after amylin injection neither in 
the AP nor in the NTS between IAPP-/- and control mice. We therefore conclude that IAPP-/- 
mice on P60 are similarly sensitive to the effect of exogenous amylin on neuronal activation 
in the AP, and that the signal transduction to the NTS as measured by c-Fos 
immunocytochemistry is not affected by amylin deficiency in adult mice. This is also 
supported by the study from our group mentioned above, which showed no difference in the 
sensitivity to the eating inhibitory effect of exogenous amylin between adult IAPP-/- and 
IAPP+/+ mice (Theis, 2009). These same mice had also been used in a parallel study to 
investigate the c-Fos expression in the AP/NTS region after amylin administration; in that 
experiment the numbers of amylin-activated cells in the AP and the NTS of IAPP-/- mice was 
significantly higher compared to IAPP+/+ mice. The different outcome between this study and 
the current finding can most likely be explained by different experimental conditions such as 
fasting time before amylin treatment and different durations between amylin injection and 
transcardial perfusion. Furthermore, mice used in the experiment by Theis (2009) were older 
than P60. It is tempting to speculate that CTR density in the AP might continue to increase 
after P60, which would explain the increased sensitivity to amylin gauged by c-Fos 
expression in older IAPP-/- mice. However, neither fiber density nor CTR density have been 
investigated in IAPP-/- mice older than P60. 
Our findings in adult IAPP-/- mice raise questions about the physiological relevance of the 
reduced fiber density in early postnatal amylin-deficient mouse pups. Although we did not 
detect significant differences in fiber density of P14 and adult IAPP-/- mice compared to 
IAPP+/+, it remains unknown if the quality of neuronal circuits is affected. Neither the signal 
transduction from the AP to the NTS nor the eating inhibition after amylin injection was 
affected by amylin deficiency in adult mice; however, this does not rule out that other 
functions mediated by the AP or other hormonal systems may be impaired. There are 
indications supporting the latter hypothesis in the finding that IAPP-/- mice showed 
differences in body weight gain between weaning and about 4 months of age compared to 
IAPP+/+; of note food intake during this period did not differ significantly between groups 
(Lutz 2006). 
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We speculate that the impaired projection development in the hindbrain during early 
postnatal life in IAPP-/- mice may have a secondary effect on the functional or anatomical 
maturation of other neuronal circuits in this particular period, leading to a neuronal 
programming that might persist throughout life. Such effects are not necessarily reflected by 
AP-NTS fiber densities, but possibly by neuroanatomical or functional deficits in downstream 
pathways connecting the AP/NTS region to forebrain areas. 
 
Finally, we adapted and established the method of DiI implantation into the ARH in order 
to investigate ARH-PVH projections. Our data are too preliminary to draw conclusions, 
although we saw a tendency towards lower fiber density in male P14 IAPP-/- mice compared 
to IAPP+/+ littermates. The analysis of a possible impact of amylin deficiency on the 
development of ARH projections will be very interesting. A recent study showed an 
amplification of hypothalamic leptin signaling, detected by c-Fos expression, after amylin 
administration (Turek et al.), although amylin itself does not activate c-Fos expression in the 
hypothalamus (Riediger et al. 2004). It will be interesting to see whether, similar to these 
synergistic neuronal mechanisms, leptin and amylin also interact as developmental 
neurotrophic factors (see below). 
 
The neurotrophic effect of leptin on the development of projections from the ARH to the 
PVH had been demonstrated by Bouret et al. (Bouret et al. 2004b). Because our studies had 
shown a similar effect for amylin on AP-NTS projections, it was of high interest to determine 
whether leptin may also exert trophic effects on axonal growth in the AP/NTS region, where 
the leptin receptor is also expressed (Dallaporta et al. 2009); this had never been tested before. 
In our study, male ob/ob mouse pups in fact showed a significantly reduced fiber density 
in the NTS compared to wildtype littermates on P14. This result is highly interesting as it 
further substantiates for a role of the adiposity signal leptin as a developmental signal, which 
seems to be important for the maturation of pathways involved in the control of energy 
balance. Based on our findings, a future approach would be the investigation of neuronal 
projections in leptin and amylin double knock out animals. A recent study led to the 
suggestion that intrinsic synergistic neuronal signaling pathways for leptin and amylin exist, 
and that their activation plays a key role in the weight- and fat-reducing effect of combined 
treatment with amylin and leptin (Turek et al.). It is therefore of high interest whether the 
neurotrophic actions of amylin and leptin on AP-NTS projections also show some sort of 
interaction. 
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The time window of ARH-PVH projection development coincides with the postnatal 
leptin surge (Ahima et al. 1998; Bouret et al. 2004b). Preliminary previous data indicated that 
the AP-NTS projections are already present on postnatal day 7 implying that their 
development takes place in the early postnatal phase or even perhaps prenatally. The AP/NTS 
region is involved in the short-term control of food intake, while the ARH is the main site for 
long-term control of body weight and energy stores. It may therefore be of importance that 
AP-NTS projections even develop prenatally, as neonates are confronted with a sudden 
change in nutritional supply at birth. The abrupt onset of ingestive behavior may require an 
already well-developed circuitry for the control of food intake. However, we can infer that 
unlike the development of ARH projections, the AP-NTS projection development does not 
coincide with the postnatal leptin surge that typically occurs between postnatal days 6 and 14. 
Like amylin (Caminos et al. 2009; Mulder et al. 1997), leptin is expressed by different fetal 
tissues and the placenta (Chen et al. 2000; Hoggard et al. 1997), which is compatible with the 
idea of a potentially prenatal trophic action of leptin in addition to its early postnatal effects. 
 
A further interesting finding in our study with leptin-deficient mice was the apparent 
genotype-specific difference in the fiber density of the long AP efferents, projecting 
ventrolaterally. We performed semi-quantitative analysis under the fluorescence microscope, 
which revealed that the density of these projections also seems to be reduced in leptin-
deficient mice. These projections have terminal fields in the nucleus ambiguus and the 
parabrachial nucleus (PBN) (Shapiro and Miselis 1985; van der Kooy and Koda 1983), but it 
remains to be elucidated if fibers to both projection sites were reduced. We hypothesize that 
fibers to the PBN may at least to some extent be affected, as the PBN plays an important role 
as a relay center, transmitting amylin signaling from the AP to rostral brain areas (Becskei et 
al. 2007). 
 
In conclusion, the current study further characterizes the neurotrophic effect of amylin on 
the development of AP-NTS projections, and also provides strong evidence for a neurotrophic 
effect of leptin on the AP-NTS projections.  
Calcitonin receptors in adult IAPP-/- mice appear to be increased, which is indicative of 
an autoregulatory mechanism adjusting receptor-ligand interactions (Huang et al. 1997; 
Kuwasako et al. 2000). Apart from that, there was no indication of alterations in the 
neuroanatomy or signal transduction in the AP/NTS region of adult IAPP-/- mice, although 
these studies require further investigation. However, we put forward the hypothesis that 
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abnormal development of neuronal circuits in early postnatal IAPP-/- mice might lead to a 
secondary functional or neuroanatomical imprinting with consequences for the adult 
individual. Which hormonal or neuronal systems are affected and whether these mechanisms 
only affect the control of energy balance remains to be elucidated. 
 
Our study provides the first evidence that leptin is necessary for the development of 
brainstem circuits involved in the control of food intake. This important finding further 
extends the concept that leptin functions as a developmental factor, which is required for 
appropriate maturation of brain circuits involved in the maintenance of energy balance. 
Possible interactions of amylin and leptin during early postnatal brain development will be 
investigated in follow up studies of ARH and AP projections in amylin / leptin double 
knockout mice. For these investigations the studies conducted in the current work constitute 
an important starting point. As put forward by a number of recent studies (Bouret et al. 2008), 
perinatal processes that modulate brain development and programming of neural circuits 
appear to be extremely important as determining risk factors for obesity and associated 
disorders later in life. 
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